7th Circuit: Testosterone Gel ‘Unsound Mind’ Claim Doesn’t Trigger Discovery Rule

Mealey's (March 30, 2022, 1:52 PM EDT) -- CHICAGO — The Seventh Circuit U.S. Court of Appeals on March 21 said issue preclusion bars a lawsuit by a federal prisoner who claims that the testosterone replacement therapy drug AndroGel caused compulsive behavior that resulted in his financial ruin and compulsive behavior that led to his conviction of fraud and money laundering in a $6.4 million scheme....